Piper Sandler analyst William Quirk raised the firm's price target on Agilent to $96 from $86 and keeps an Overweight rating on the shares. The Agilent reported fiscal Q1 core revenue growth of 2.4% with non-GAAP earnings per share of 81c, in line with the Street's expectations, Quirk tells investors in a research note. Management reiterated fiscal 2020 guidance and issued Q2 guidance below the Street's estimates due to potential impacts from coronavirus, the analyst adds. He believes Agilent has a number of growth drivers this year, and continues to believe coronavirus will be a "transient item."